Gmtp.Wa
GMTP.WA operates in the healthcare diagnostics segment, focusing on biotechnology and medical research to develop diagnostic solutions and related technologies.
Business. GMTP.WA operates in the healthcare diagnostics segment, focusing on biotechnology and medical research to develop diagnostic solutions and related technologies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
GMTP.WA operates in the healthcare diagnostics segment, focusing on biotechnology and medical research to develop diagnostic solutions and related technologies.
The company's capital structure is characterized by a debt-to-equity ratio of 0.31, indicating a relatively conservative leverage position. However, the liquidity risk is assessed as medium, with a current ratio of 1.55, suggesting the company has sufficient short-term assets to cover its liabilities, but not with a large margin of safety. The negative operating and free cash flows of -6.72 million and -8.94 million, respectively, highlight the company's ongoing cash burn, which could pressure liquidity in the near term.
Profitability metrics are deeply negative, with a return on equity of -147.47% and a return on assets of -65.77%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. The gross profit of -4.31 million and operating income of -11.06 million further underscore the company's unprofitable operations. These results are significantly below the industry median for profitability metrics, suggesting a challenging competitive position.
The company's revenue is concentrated in a single entity, with no disclosed geographic or segment diversification. This lack of diversification increases the risk of revenue volatility and exposure to market-specific downturns. The absence of segment or geographic breakdown in the financial data limits the ability to assess the company's exposure to different markets or product lines.
The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year. The negative operating and free cash flows suggest that the company is not in a position to fund growth organically and may require external financing. The lack of capital expenditure, with a value of -59,000, indicates minimal investment in long-term assets, which could hinder future growth.
The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could necessitate additional financing. However, the dilution risk is assessed as low, suggesting that the company is not expected to issue a significant number of new shares in the near term. The absence of dilution sources in the risk assessment indicates that the company has not disclosed any imminent plans for share issuance or other dilutive events.
Recent events and filings do not provide specific details on the company's operations or strategic direction. The lack of disclosed events or transcripts limits the ability to assess the company's recent performance or management's outlook.
- GMTP.WA is operating at a significant loss, with negative returns on equity and assets.
- The company's liquidity position is medium risk, with a current ratio of 1.55 and negative operating and free cash flows.
- The company's revenue is not diversified by segment or geography, increasing exposure to market-specific risks.
- The company is not investing in capital expenditures, which could hinder long-term growth.
- The company's dilution risk is low, but its liquidity risk remains a concern due to negative net cash after debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- GMTP.WA Market data — financials · 2026-05-28